Medicare Advantage Tied to Less Use of Pricey Diabetes Drugs

Data from more than 400,000 Medicare beneficiaries showed a significant link between less prescribing of SGLT2 inhibitors and GLP-1 agonists and enrollment in a Medicare Advantage plan.
Medscape Medical News